CHINA UNICOM
00762
PCCW
00008
CHINA TELECOM
00728
EB ENVIRONMENT
00257
FE HORIZON
03360
HK Stock MarketDetailed Quotes
09969 INNOCARE
- 6.060
- -0.030-0.49%
Not Open Dec 19 16:08 CST
10.68BMarket Cap-25.68P/E (TTM)
6.130High5.830Low4.71MVolume6.000Open6.090Pre Close28.20MTurnover0.32%Turnover RatioLossP/E (Static)1.76BShares7.92052wk High1.42P/B9.07BFloat Cap4.03052wk Low--Dividend TTM1.50BShs Float32.050Historical High--Dividend LFY4.93%Amplitude4.030Historical Low5.982Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
About INNOCARE Company
The company is a commercialized biomedical high-tech company. It was co-founded in 2015 by Dr. Cui Jisong, who has extensive experience in new drug development and enterprise management, and Academician Shi Yigong, a world-famous structural biologist. We develop innovative drugs for patients with malignant tumors and autoimmune diseases, so that innovative results can benefit more patients. The company is a high-tech innovative biomedical enterprise with excellent independent research and development capabilities as the core driving force. It has comprehensive R&D, production and commercialization capabilities, focuses on fields such as tumors and autoimmune diseases where there are huge unmet clinical needs, and develops first-of-its-kind or best-in-class drugs with breakthrough potential in the global market. Main products: obutinib, ICP-B04, ICP-248, ICP-B02, ICP-490, ICP-B05, ICP-332, ICP-488, ICP-B02, ICP-923, ICP-723,, ICP-192, etc. ICP-189
Company Profile
Symbol09969
Company NameINNOCARE
ISINKYG4783B1032
Listing DateMar 23, 2020
Issue Price8.95
Shares Offered250.32M share(s)
FoundedNov 3, 2015
Registered AddressCayman Islands
Chairmanjisong cui
Secretaryxiepeishan li
Audit InstitutionErnst & Young, Ernst & Young Huaming
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeOgier Global (Cayman) Limited's offices 89 Nexus Way Camana Bay Grand Cayman, KY1-9009 Cayman Islands
Head Office and Principal Place of Business40th Floor, Dah Sing Finance Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees1109
MarketHong Kong motherboard
Phone(86)1066609999
Fax(86)1060702992
Emailinfo@innocarepharma.com
BusinessNuochengjianhua is an innovative biomedical enterprise with excellent independent research and development capabilities as the core driving force. It has comprehensive R&D and commercialization capabilities, focuses on fields such as tumors and autoimmune diseases where there are huge unmet clinical needs, and develops best-in-class or first-of-its-kind drugs with breakthrough potential in the global market.
Company Executives
- Name
- Position
- Salary
- jisong cui
- Presidencies, CEO, Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
- --
- renbin zhao
- Executive Director
- --
- yigong shi
- Non-executive Directors
- --
- dandan dong
- Independent Non-Executive Director, Audit Committee Members, Remuneration Committee Members, Nomination Committee Members
- 80.00K
- ronggang xie
- Non-executive Directors, Audit Committee Members
- --
- lan hu
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Chairman, Nomination Committee Members
- --
- xin fu
- Chief Financial Officer
- --
- xiangyang zhang
- Chief Medical Officer
- --
- xiangyang chen
- Chief Technology Officer
- --
- xiepeishan li
- Authorized Representative, Company Secretary
- --
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
